12 Nov SAHPRA warns the public about GLP-1 products sold through social media platforms Pretoria, 11 November 2025 The South African Health Products Regulatory Authority (SAHPRA) cautions members of the public against purchasing or using GLP-1 (glucagon-like peptide-1) products that are being promoted and sold on various social media platforms
For GLP-1 RAs, projected QALY gain was 36,090 at a total healthcare cost increment of AU$2.9 billion, resulting in an ICER of AU$79,742 per QALY gained
Our products have been predominantly formulated for skincare to heal the problems of pigmentation, acne, and tanning
they have also been found to boost plant growth performance, antioxidant activities, and tolerance to abiotic stress 27,28
Good habits become identity and promote human flourishing